Search Results - "Naguib, Fardos N.M."

Refine Results
  1. 1

    Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum by Naguib, Fardos N.M., Wilson, Craig M., el Kouni, Mahmoud H.

    “…Malaria remains a significant public health problem worldwide with an estimated annual global incidence of 200 million and an estimated 450,000 annual deaths…”
    Get full text
    Journal Article
  2. 2

    5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase by el Kouni, Mahmoud H, Goudgaon, Naganna M, Rafeeq, Mohammad, Al Safarjalani, Omar N, Schinazi, Raymond F, Naguib, Fardos N.M

    Published in Biochemical pharmacology (15-09-2000)
    “…5-Phenylthioacyclouridine (PTAU or 1-[(2-hydroxyethoxy)methyl]-5-phenylthiouracil) was synthesized as a highly specific and potent inhibitor of uridine…”
    Get full text
    Journal Article
  3. 3

    Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine by Ashour, Osama M, Naguib, Fardos N.M, Panzica, Raymond P, Al Safarjalani, Omar N, el Kouni, Mahmoud H

    Published in Biochemical pharmacology (01-08-2000)
    “…Administration of 200 mg/kg of 5-fluorouracil (FUra) to mice bearing human colon carcinoma DLD-1 xenografts resulted in 100% mortality. Oral administration of…”
    Get full text
    Journal Article
  4. 4

    Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2′-deoxyuridine against murine colon tumor C26–10 by Ashour, Osama M, Naguib, Fardos N.M, Goudgaon, Naganna M, Schinazi, Raymond F, el Kouni, Mahmoud H

    Published in Biochemical pharmacology (01-09-2000)
    “…The effect of co-administration of 5-(phenylselenenyl)acyclouridine (PSAU), a new uridine phosphorylase (UrdPase, EC 2.4.2.3) inhibitor, on the efficacy of…”
    Get full text
    Journal Article
  5. 5

    Nucleoside kinases in adult Schistosoma mansoni: Phosphorylation of pyrimidine nucleosides by Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Molecular and biochemical parasitology (01-03-2014)
    “…•Adults Schistosoma mansoni contain three nucleoside kinases that can phosphorylate pyrimidine nucleosides.•A non-specific deoxyriboside kinase (EC 2.7.1.145)…”
    Get full text
    Journal Article
  6. 6

    Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine by Naguib, Fardos N.M., Rais, Reem H., Al Safarjalani, Omar N., el Kouni, Mahmoud H.

    “…Initial velocity and product inhibition studies of Toxoplasma gondii adenosine kinase (TgAK, EC 2.7.1.20) demonstrated that the basic mechanism of this enzyme…”
    Get full text
    Journal Article
  7. 7

    Synthesis of [4-(hydroxy)tetrahydrofuran-2-yl]nucleosides as a novel class of uridine phosphorylase inhibitors by Yang, Te-Fang, Kotra, Lakshmi P., Teng, Quincy, Naguib, Fardos N.M., Sommadossi, Jean-Pierre, el Kouni, Mahmoud, Chu, Chung K.

    Published in Tetrahedron letters (13-02-1995)
    “…[4-(Hydroxy)tetrahydrofuran-2-yl]thymine was synthesized and found to be a potent inhibitor of uridine phosphorylase. [4-(Hydroxy)tetrahydrofuran-2-yl]thymine…”
    Get full text
    Journal Article
  8. 8

    Synthesis, biological evaluation and molecular modeling studies of N 6-benzyladenosine analogues as potential anti-toxoplasma agents by Kim, Young Ah, Sharon, Ashoke, Chu, Chung K., Rais, Reem H., Al Safarjalani, Omar N., Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Biochemical pharmacology (15-05-2007)
    “…Toxoplasma gondii is an opportunistic pathogen responsible for toxoplasmosis. T. gondii is a purine auxotroph incapable of de novo purine biosynthesis and…”
    Get full text
    Journal Article
  9. 9

    Synthesis, biological evaluation and molecular modeling studies of N-benzyladenosine analogues as potential anti-toxoplasma agents by Kim, Young Ah, Sharon, Ashoke, Chu, Chung K, Rais, Reem H, Safarjalani, Omar N Al, Naguib, Fardos N M, el Kouni, Mahmoud H

    Published in Biochemical pharmacology (15-05-2007)
    “…Toxoplasma gondii is an opportunistic pathogen responsible for toxoplasmosis. T. gondii is a purine auxotroph incapable of de novo purine biosynthesis and…”
    Get full text
    Journal Article
  10. 10

    Structure−Activity Relationships of 7-Deaza-6-benzylthioinosine Analogues as Ligands of Toxoplasma gondii Adenosine Kinase by Kim, Young Ah, Sharon, Ashoke, Chu, Chung K, Rais, Reem H, Al Safarjalani, Omar N, Naguib, Fardos N. M, el Kouni, Mahmoud H

    Published in Journal of medicinal chemistry (10-07-2008)
    “…Several 7-deaza-6-benzylthioinosine analogues with varied substituents on aromatic ring were synthesized and evaluated against Toxoplasma gondii adenosine…”
    Get full text
    Journal Article
  11. 11

    Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: Biological activities and selective toxicities by Al Safarjalani, Omar N., Rais, Reem H., Kim, Young Ah, Chu, Chung K., Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Biochemical pharmacology (01-10-2010)
    “…Novel carbocyclic 6-benzylthioinosine analogues are subversive substrates of Toxoplasma gondii adenosine kinase and selectively kill the parasites. Toxoplasma…”
    Get full text
    Journal Article
  12. 12

    Structure–activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase by Kim, Young Ah, Rawal, Ravindra K., Yoo, Jakyung, Sharon, Ashoke, Jha, Ashok K., Chu, Chung K., Rais, Reem H., Al Safarjalani, Omar N., Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Bioorganic & medicinal chemistry (15-05-2010)
    “…Carbocyclic 6-benzylthioinosine analogues were synthesized and evaluated for their binding affinity against Toxoplasma gondii adenosine kinase [EC.2.7.1.20]…”
    Get full text
    Journal Article
  13. 13

    Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity by Al Safarjalani, Omar N., Rais, Reem, Naguib, Fardos N. M., el Kouni, Mahmoud H.

    Published in Cancer chemotherapy and pharmacology (01-06-2012)
    “…Purpose The purpose of this investigation was to evaluate the effectiveness of oral 5-(phenylthio)acyclouridine (PTAU) in reducing 5-fluorouracil (FUra) host…”
    Get full text
    Journal Article
  14. 14
  15. 15

    7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities by Al Safarjalani, Omar N., Rais, Reem H., Ah Kim, Young, Chu, Chung K., Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Biochemical pharmacology (15-10-2008)
    “…Toxoplasma gondii adenosine kinase (EC.2.7.1.20) is the major route of adenosine metabolism in this parasite. The enzyme is significantly more active than any…”
    Get full text
    Journal Article
  16. 16

    Synthesis, Biological Activity and Molecular Modeling of 6-Benzylthioinosine Analogues as Subversive Substrates of Toxoplasma gondii Adenosine Kinase by YADAV, Vikas, CHU, Chung K., RAIS, Reem H., AL SAFARJALANI, Omar N., GUARCELLO, Vincenzo, NAGUIB, Fardos N. M.

    Published in Journal of medicinal chemistry (08-04-2004)
    “…Toxoplasma gondii is the most common cause of secondary CNS infections in immunocompromised persons such as AIDS patients. The major route of adenosine…”
    Get full text
    Journal Article
  17. 17

    6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities by Rais, Reem H., Al Safarjalani, Omar N., Yadav, Vikas, Guarcello, Vincenzo, Kirk, Marion, Chu, Chung K., Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Biochemical pharmacology (15-05-2005)
    “…Toxoplasma gondii adenosine kinase (EC.2.7.1.20) is the major route of adenosine metabolism in this parasite. The enzyme is significantly more active than any…”
    Get full text
    Journal Article
  18. 18

    Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity by Guarcello, Vincenzo, Blanquicett, Carmelo, Naguib, Fardos N. M., el Kouni, Mahmoud H.

    Published in Cancer chemotherapy and pharmacology (01-06-2008)
    “…Purpose Thymidine phosphorylase (TP, EC 2.4.2.4) activity varies in different human cancer cell lines. Nevertheless, little is known about the regulatory…”
    Get full text
    Journal Article
  19. 19

    6-Benzylthioinosine analogues: Promising anti-toxoplasmic agents as inhibitors of the mammalian nucleoside transporter ENT1 ( es) by Gupte, Amol, Buolamwini, John K., Yadav, Vikas, Chu, Chung K., Naguib, Fardos N.M., el Kouni, Mahmoud H.

    Published in Biochemical pharmacology (19-12-2005)
    “…Certain 6-benzylthioinosine analogues have been identified as potential chemotherapeutic agents against Toxoplasma gondii in cell culture and animal models…”
    Get full text
    Journal Article
  20. 20

    Uptake of Nitrobenzylthioinosine and Purine β-l-Nucleosides by Intracellular Toxoplasma gondii by Al Safarjalani, Omar N, Naguib, Fardos N M, El Kouni, Mahmoud H

    Published in Antimicrobial Agents and Chemotherapy (01-10-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article